Sweet-Syndrome under adjuvant Therapy with Pembrolizumab in a Patient with metastatic Melanoma

被引：0
|
作者：
Bley, L. I.
Braun, S. A.
Weishaupt, C.
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P58
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [1] Sweet-Syndrome in Ipilimumab- Therapy in Combination with Radiotherapy in a Patient with metastatic malignant Melanoma
    Kleffner-Mieth, F.
    Brenner, N.
    Tantcheva-Poor, I
    Schlaak, M.
    Mauch, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 (12): : 1325 - 1325
  • [2] Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy
    Pintova, Sofya
    Sidhu, Harleen
    Friedlander, Philip A.
    Holcombe, Randall F.
    MELANOMA RESEARCH, 2013, 23 (06) : 498 - 501
  • [3] Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma
    Adler, N. R.
    Murray, W. K.
    Brady, B.
    McCormack, C.
    Pan, Y.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (04) : 497 - 499
  • [4] Bullous Pemphigoid under Pembrolizumab Therapy by Metastatic Malignant Melanoma
    Troyanova-Slavkova, S.
    Schierle, K.
    Beloia, S. -D.
    Kowalzick, L.
    AKTUELLE DERMATOLOGIE, 2018, 44 (10) : 441 - 446
  • [5] Immunotherapy-associated Sweet syndrome in a patient with metastatic melanoma
    Barry, Rory
    Murray, Gregg
    Eustace, Karen
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [6] Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma
    Stuart, Laura
    Lambourne, Beth
    Turner, Paul
    Jones, David E. J.
    Plummer, Ruth
    Cresti, Nicola
    Dyson, Jessica K.
    HEPATOLOGY, 2020, 71 (06) : 2164 - 2166
  • [7] Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report
    Barry, Rory
    Murray, Gregg
    McGrath, Sally
    Kilgallen, Clive
    Eustace, Karen
    JEADV CLINICAL PRACTICE, 2024, 3 (04): : 1267 - 1269
  • [8] A rapid response to pembrolizumab in a patient with metastatic melanoma
    Bayo Calero, Juan
    Avino Tarazona, Victoria
    IMMUNOTHERAPY, 2017, 9 (03) : 225 - 228
  • [9] A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
    Wu, Lili
    Li, Bixun
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 753 - 757
  • [10] Induction of autoimmune hemolytic Anemia under adjuvant Therapy with Pembrolizumab in Patients with malignant Melanoma
    Giulini, M.
    Mueller-Brenne, T.
    Pemler, S.
    Henning, B.
    Heinz, J.
    Gruhn, S.
    Kolgraf, L.
    Grabbe, S.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 78 - 78
12345